Company Filing History:
5 out of 96 
5 out of 321 
5 out of 13 
Years Active: 2008-2021
Title: The Innovations of Jean-Pierre Le Couedic
Introduction
Jean-Pierre Le Couedic is a notable inventor based in Champs sur Marne, France. He has made significant contributions to the field of medical diagnostics, particularly in relation to myeloproliferative disorders. With a total of six patents to his name, his work has had a profound impact on the understanding and diagnosis of certain blood conditions.
Latest Patents
One of his latest patents focuses on the identification of a JAK2 mutation in polycythemia vera. This invention concerns the V617F variant of the protein-tyrosine kinase JAK2, which is responsible for Vaquez Polyglobulia. The invention also relates to a first intention diagnostic method for erythrocytosis and thrombocytosis, allowing their association with myeloproliferative disorders. Additionally, it enables the detection of the JAK2 V617F variant in myeloproliferative disorders, facilitating their reclassification into a new nosological group.
Career Highlights
Throughout his career, Jean-Pierre Le Couedic has worked with prestigious institutions such as Institut Gustave Roussy and Assistance Publique-Hôpitaux de Paris. His expertise in the field has led to advancements in diagnostic methods that are crucial for patient care.
Collaborations
He has collaborated with esteemed colleagues, including William Vainchenker and Nicole Casadevall. These partnerships have further enriched his research and innovations in the medical field.
Conclusion
Jean-Pierre Le Couedic's contributions to medical diagnostics, particularly through his patents related to JAK2 mutations, highlight his importance as an inventor. His work continues to influence the diagnosis and treatment of blood disorders, showcasing the vital role of innovation in healthcare.